Literature DB >> 3194120

The isolation and serology of the "FSA" Brucella melitensis Rev. 1 mutant in a flock of sheep.

S M Pefanis1, B Gummow, P M Pieterson, C C Williamson, C G Venter, S Herr.   

Abstract

A flock of sheep, known to be infected with the "FSA" mutant of Brucella melitensis Rev. 1, was examined serologically and bacteriologically to determine whether any relationship existed which would help in the control of this infection in the field. An attempt was also made to determine whether vertical transmission occurred. Twenty-one out of 62 sheep were bacteriologically positive. The best organs for isolation were the udder, supramammary lymphnodes and uterus. No significant relationship could be shown between the complement fixation test and bacterial isolation. The absence of any relationship between serological and bacteriological results agrees with a short-lived infection. None of the 24 lambs sacrificed at 5 months showed either serological reactions or were bacteriologically positive, thus no vertical transmission could be shown.

Entities:  

Mesh:

Year:  1988        PMID: 3194120

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  3 in total

1.  Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene.

Authors:  Svetlana Bardenstein; Michal Mandelboim; Thomas A Ficht; Miriam Baum; Menachem Banai
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Molecular typing of Brucella melitensis endemic strains and differentiation from the vaccine strain Rev-1.

Authors:  Georgios T Noutsios; Rigini M Papi; Loukia V Ekateriniadou; Anastasios Minas; Dimitrios A Kyriakidis
Journal:  Vet Res Commun       Date:  2011-10-22       Impact factor: 2.459

3.  Vaccine Candidate Brucella melitensis 16MΔvjbR Is Safe in a Pregnant Sheep Model and Confers Protection.

Authors:  Martha E Hensel; Daniel G Garcia-Gonzalez; Sankar P Chaki; Airn Hartwig; Paul W Gordy; Richard Bowen; Thomas A Ficht; Angela M Arenas-Gamboa
Journal:  mSphere       Date:  2020-05-13       Impact factor: 4.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.